Understanding how CLPB mutations affect blood cell production
Mechanisms of Impaired Granulopoiesis Due to CLPB Mutations
This study is looking at how changes in the CLPB gene affect the production of important white blood cells in people with severe congenital neutropenia, with the goal of finding better treatments for those living with this condition.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Children's Hosp of Philadelphia NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10884431 on NIH RePORTER |
What this research studies
This research investigates the underlying mechanisms of severe congenital neutropenia (SCN) caused by mutations in the CLPB gene. It focuses on how these mutations disrupt the normal formation of granulocytes, a type of white blood cell essential for fighting infections. By using advanced techniques like exome sequencing and studying the cellular responses to stress in blood cell precursors, the research aims to clarify how impaired CLPB function leads to reduced blood cell production. This could ultimately help in developing targeted therapies for patients with SCN.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with severe congenital neutropenia, particularly those with identified CLPB mutations.
Not a fit: Patients without congenital neutropenia or those whose condition is not linked to CLPB mutations may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that improve blood cell production and reduce infection risks for patients with SCN.
How similar studies have performed: Previous research has shown promising results in understanding genetic causes of blood disorders, suggesting that this approach could yield valuable insights.
Where this research is happening
Philadelphia, United States
- Children's Hosp of Philadelphia — Philadelphia, United States (Active)
Researchers
- Principal investigator: Warren, Julia Therese — Children's Hosp of Philadelphia
- Study coordinator: Warren, Julia Therese
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.